Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Anthenelli RM, et al. Among authors: ascher j. Lancet. 2016 Jun 18;387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22. Lancet. 2016. PMID: 27116918 Clinical Trial.
Impact of prior nicotine replacement therapy on smoking cessation efficacy.
Durcan MJ, White J, Jorenby DE, Fiore MC, Rennard SI, Leischow SJ, Nides MA, Ascher JA, Johnston JA. Durcan MJ, et al. Among authors: ascher ja. Am J Health Behav. 2002 May-Jun;26(3):213-20. doi: 10.5993/ajhb.26.3.6. Am J Health Behav. 2002. PMID: 12018757 Clinical Trial.
Bupropion hydrochloride in attention deficit disorder with hyperactivity.
Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J. Conners CK, et al. Among authors: ascher j. J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1314-21. doi: 10.1097/00004583-199610000-00018. J Am Acad Child Adolesc Psychiatry. 1996. PMID: 8885585 Clinical Trial.
Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.
Kittle J, Lopes RD, Huang M, Marquess ML, Wilson MD, Ascher J, Krishen A, Hasselblad V, Kolls BJ, Roe MT, McGuire DK, Russell SD, Mahaffey KW. Kittle J, et al. Among authors: ascher j. Clin Cardiol. 2017 Oct;40(10):899-906. doi: 10.1002/clc.22744. Epub 2017 Jun 12. Clin Cardiol. 2017. PMID: 28605035 Free PMC article.
Dose-related reduction in bupropion plasma concentrations by ritonavir.
Park J, Vousden M, Brittain C, McConn DJ, Iavarone L, Ascher J, Sutherland SM, Muir KT. Park J, et al. Among authors: ascher j. J Clin Pharmacol. 2010 Oct;50(10):1180-7. doi: 10.1177/0091270009359524. Epub 2010 May 19. J Clin Pharmacol. 2010. PMID: 20484617
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page